SHED-CM contains components such as VEGF and HGF, which are known to be effective against neurological diseases, including ALS, and cytokines, such as MCP-1, which promote M1/M2 shift changes (Table 6). The gene discussed is HGF; the disease is amyotrophic lateral sclerosis.